Tracheotomy: a method for transplantation of stem cells to the lung.
Lung disease is a leading cause of death and likely to become an epidemic given increases in pollution and smoking worldwide. Advances in stem cell therapy may alleviate many of the symptoms associated with lung disease and induce alveolar repair in adults. Concurrent with the ongoing search for stem cells applicable for human treatment, precise delivery and homing (to the site of disease) must be reassured for successful therapy. Here, I report that stem cells can safely be instilled via the trachea opening a non-stop route to the lung. This method involves a skin incision, caudal insertion of a cannula into and along the tracheal lumen, and injection of a stem cell vehicle mixture into airways of the lung. A broad range of media solutions and stabilizers can be instilled via tracheotomy, resulting in the ability to deliver a wider range of cell types. With alveolar epithelium confining these cells to the lumen, lung expansion and negative pressure during inhalation may also assist in stem cell integration. Tracheal delivery of stem cells, with a quick uptake and the ability to handle a large range of treatments, could accelerate the development of cell-based therapies, opening new avenues for treatment of lung disease.
Peter
Yakov
Y
Department of Cell Biology, Harvard Medical School, Boston, MA, USA. yakov_peter@hms.harvard.edu
D000818:Animals; D002404:Catheterization; D007267:Injections; D008168:Lung / Q000601:surgery*; D051379:Mice; D033581:Stem Cell Transplantation / Q000379:methods*; D014140:Tracheotomy; D015919:Ventilators, Negative-Pressure